Houghton, P. J., Maris, J. M., Friedman, H. S., Keir, S. T., Lock, R. B., Carol, H., … Smith, M. A. (2007). Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454. MOLECULAR CANCER THERAPEUTICS, 6(12), 3405S-3405S.

Houghton, Peter J., John M. Maris, Henry S. Friedman, Stephen T. Keir, Richard B. Lock, Hernan Carol, Richard Gorlick, et al. “Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454.” MOLECULAR CANCER THERAPEUTICS 6, no. 12 (December 1, 2007): 3405S-3405S.

Houghton PJ, Maris JM, Friedman HS, Keir ST, Lock RB, Carol H, et al. Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454. MOLECULAR CANCER THERAPEUTICS. 2007 Dec 1;6(12):3405S-3405S.

Houghton, Peter J., et al. “Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454.” MOLECULAR CANCER THERAPEUTICS, vol. 6, no. 12, AMER ASSOC CANCER RESEARCH, Dec. 2007, pp. 3405S-3405S.

Houghton PJ, Maris JM, Friedman HS, Keir ST, Lock RB, Carol H, Gorlick R, Kolb EA, Keshlava N, Reynolds CP, Morton CL, Smith MA. Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454. MOLECULAR CANCER THERAPEUTICS. AMER ASSOC CANCER RESEARCH; 2007 Dec 1;6(12):3405S-3405S.